Indeed some reports suggest that the GSTM1 genetic polymorphism may affect AFB 1 detoxification in human liver
A 2025 review in Mayo Clinic Proceedings reports that 40% to 70% of patients on these medications experience gastrointestinal side effects, and that first-line management is dietary: smaller and more frequent meals, adequate hydration, and steering clear of high-fat and high-sugar foods
But you can minimize intensity and duration through strategic product introduction
A proper glp-1 injection technique helps ensure steady, predictable results
For medspa owners and healthcare providers, the takeaway is simple: Trust your compounding sources, document your compliance, and stay ahead of FDA enforcement trends
eating first further modifies the absorption curve in a more predictable way and helps buffer glucose effects